MOCAN HOGNOGI, L. D.; SIMITI, L. V. THE CARDIOVASCULAR IMPACT OF VISFATIN - AN INFLAMMATION PREDICTOR BIOMARKER IN METABOLIC SYNDROME. Medicine and Pharmacy Reports, [S. l.], v. 89, n. 3, p. 322–326, 2016. DOI: 10.15386/cjmed-591. Disponível em: https://medpharmareports.com/index.php/mpr/article/view/591. Acesso em: 11 jul. 2025.